Upregulated exhaustion markers on CD4+ T cell populations in lymphedema might reflect not only chronic consumption of effector CD4+ T cells but also the counterbalancing enhancement of suppressed function to inhibit the progress of tissue inflammation and fibrosis. This evidence concerns the gene CD4 and lymphedema.